Endocrine Abstracts

Second malignant neoplasm following irradiation is a rare sequelae of primary childhood malignancies. Irradiation is a well-known risk factor for the development of benign and malignant thyroid tumors. Here we present the case of a young woman with medulloblastoma, who later developed thyroid cancer and eventually was also diagnosed with a cholangiocarcinoma.At the age of 7 the patient presented with headaches, nausea, vomiting, fatigue, somnolence and d...

We present a case of a 24 year old lady with known SDHB mutation. She was referred from the genetics clinic in view of a strong family history of premature paraganglioma at the age of 17. On initial clinic assessment she exhibits no symptoms suggestive of paraganglioma or pheochromocytoma. Her blood pressure is normal at 120/75. pulse of 60–80bpm. Physical examination was unremarkable Her Plasma normetanephrine done on two separate occasion were elevated at 1600 pmol/l a...

Introduction: In a US study of general practitioners, 50%-60% of their working time was found to be dedicated to paperwork and electronic medical record-keeping (including electronic prescription – EPC writing)1.Aim: Given the mandatory use of EPC in Greece, we wanted to assess the time required for this in the daily practice of our outpatient endocrinology clinic.Method: In one of the outpatient (OUP) clinics of t...

Introduction: Multiple endocrine neoplasia (MEN) is a rare genetic syndrome characterized by occurrence of tumors involving two or more endocrine glands. Four types are described: MEN1, MEN2, MEN3 and the recently identi&#-1279;ed MEN4. Due to the complexity of the syndromes, it is difficult to manage these patients. Our objective was to describe the clinical features of individuals from 7 families with a diagnosis of MEN1 or MEN2 and identify current challenges in clinical pr...

Multiple endocrine neoplasya type 2 (MEN-2) is a rare hereditary complex disorder caused by a germline activating mutation of the RET proto-oncogene. The estimated prevalence is approximately 1:30.000. Three clinical forms have been described depending on the phenotype: MEN2A (80%), MEN2B and familial medullary thyroid carcinoma (MTC).Clinically, MEN2A present with MTC (80–100%), unilateral or bilateral pheocromocytoma (40%) and primary hyperparath...